Skip to main content
European Commission logo
enen
Public Health

Call for EMA committees and board members

Open calls

Representatives of Patients' Associations and Clinicians: Reopening of the Call for expressions of interest for the EMA Committee for Advanced Therapies(EMA CAT) 

The Commission is re-opening the selection procedure to appoint the Representatives of Patients' Associations and Clinicians in the Committee for Advanced Therapies of the European Medicines Agency, originally launched on 12 August 2024.The reopening is necessary because the number of eligible candidates following the initial evaluation was insufficient to fill the available positions. Please note that the conditions of the original Call remain unchanged. Candidates who have previously applied will be considered without the need for resubmission. For further details, please refer to point 7 of the Call for expression of interest.

The Commission shall appoint:

  • Two members and two alternates representing clinicians
  • Two members and two alternates representing patients' associations

The successful candidates shall be appointed for a three-year-mandate starting on 1 July 2025.

All documents related to this Call are available below:

The deadline for submission of applications is 9 December 2024, 11:59 pm, Brussels time.

Decisions appointing members and experts

On this page you will find recent results of the calls for expressions of interests for positions on the EMA scientific committees and other appointing decisions.

EMA CAT Committee

EMA COMP Committee:

EMA PDCO Committee

EMA PRAC Committee

Frequently asked questions (FAQ)

Are the applicants required to be EU nationals?

Citizenship of an EU Member State is only required in case of applications for Management Board members.

The calls for members and alternates of scientific committees do not include a requirement of possession of EU Member State citizenship. However, it should be noted that EMA is a European Agency, embedded in the EU regulatory environment and with practical implementation in the EU Member States. The purpose of nominating members from interested parties is to ensure appropriate representation of stakeholders from across the EU.

What is the workload? How much time do the committee members spend on preparation for the meetings and in the meetings?

The approximate workload is indicated in the call. Depending on the Committee it is between 2 and 4 days of the actual meeting per month and some additional preparatory and follow-up work outside plenary meetings. You can find more information about the workload on EMA webpages for the relevant committee. See in particular: work plan, agendas and outcomes. This gives you an indication of the workload.

What are the costs reimbursed and allowances received?

The committee members are reimbursed for participation in the plenary committee meeting with regard to travel, accommodation and daily allowance in accordance with rules specified in the EMA document: "Rules for reimbursement of expenses for delegates and experts attending meetings" (effective from 14 June 2019).

What are the rules of participation for the "alternates"?

The rules of participation of "alternates" are set in the Rules of Procedures of the relevant committee. You can access this document on the EMA webpages for the relevant committee. In general, an alternate represents and votes for the nominated member in the absence of the member, when he/she is not attending the meeting. The alternates, however, are always welcome to participate in the meeting, but their cost will only be reimbursed if the member does not participate.

What is the timeline of the selection process, when can I expect an answer?

Upon submission of your application you will receive a confirmation of receipt (in general within 48 hours, but please bear in mind public and Commission holidays). Should you not receive a confirmation, please send the message again to: SANTE-CALL-AGENCIESatec [dot] europa [dot] eu (SANTE-CALL-AGENCIES[at]ec[dot]europa[dot]eu) . Never delete the original message, because it can serve as a proof of your submission within the deadline.

The full process of the selection and appointment by the European Commission or the European Council is quite long and may take approximately 1 year for Commission appointments and up to 1 year and a few months for the Council appointments (the call indicates who will appoint the concerned members).

All applicants will receive an answer when the Appointing Decision is published.

Are late applications accepted?

Late applications (i.e.: applications sent after the deadline) are not accepted as a general rule. In exceptional circumstances, like for example: the unavailability of the Commission server shortly before the expiry of the deadline; the Selection Panel can decide to accept late applications if duly justified.

The call indicates that "Organisations can put forward (i.e. support by a recommendation letter) more than one candidate".
Should the organisations indicate who is suggested as a member and who as an alternate?

It is preferable not to indicate whom the organisation recommends as a member and whom as an alternate. This information would not by any means influence the eligibility of members or decision on the nomination for any of the positions.

Previous calls

Representatives of Patients' Associations and Clinicians: Call for expressions of interest is open for the EMA Committee for Advanced Therapies

The Commission launched a selection procedure to appoint the Representatives of Patients' Associations and Clinicians in the Committee for Advanced Therapies of the European Medicines Agency.

The Commission shall appoint:

  • Two members and two alternates representing clinicians
  • Two members and two alternates representing patients' associations

The successful candidates shall be appointed for a three-year-mandate starting on 1 July 2025.

All documents related to this Call are available below:

The deadline for submission of applications was 4 November 2024, 11:59 pm, Brussels time.

Civil Society representatives: Call for expressions of interest is open for the EMA Management Board

The Commission launched a selection procedure to appoint the Civil Society representatives in the Management Board of the European Medicines Agency (EMA).

Four members from Civil Society shall be appointed: two members representing patients' organisations, one member representing doctors' organisations and one member representing veterinarians' organisations.

The successful candidates will be appointed for a three-year-mandate starting on 15 June 2025.

All documents related to this Call are available below:

The deadline for submission of applications was 4 November2024, 11:59 pm, Brussels time.

We encourage the applicants to consult also the web page of the Frequently Asked Question as well as consulting this webpage regularly for potential updates of documents or new information.

Additional information:

Representatives of Patients’ Organisations and Healthcare professionals: Call for expressions of interest is open for the EMA Pharmacovigilance Risk Assessment Committee

The Commission launched a selection procedure to appoint representatives of patients’ organisations and healthcare professionals in the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA).

The Commission shall appoint:

  • One member and one alternate representing patients' organisations
  • One member and one alternate representing healthcare professionals

The successful candidates will be appointed for a three-year-mandate starting on 2 May 2025.
All documents related to this Call are available below:

The deadline for submission of applications was14 October 2024 at 11:59 pm, Brussels time.

Independent Scientific experts: Call for expressions of interest for the EMA PRAC Committee

The Commission launched a selection procedure to appoint the Independent Scientific Experts to the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA).

Six Independent scientific experts were appointed.

The successful candidates were appointed for a three-year-mandate starting on 2 July 2024.

The Application Form and Declaration of Interests Form can be downloaded here:

The call was prolonged and the new final deadline for submission of applications was 12:00 noon, Brussels time, 21 December 2023.

Members representing patients’ organisations: Call for expressions of interest for the EMA COMP Committee

The Commission launched a selection procedure to appoint the members representing patients’ organisations to the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA).

Three members were appointed.

The successful candidates were appointed for a three-year-mandate starting on 1 July 2024.

The Application Form and Declaration of Interests Form can be downloaded here:

The call was prolonged and the new final deadline for submission of applications was 12:00 noon, Brussels time, 21 December 2023.

Civil Society representatives: Call for expressions of interest for the EMA PDCO Committee

The Commission launched a selection procedure to appoint the Civil Society representatives to the Pediatric Committee (PDCO) of the European Medicines Agency (EMA), in Amsterdam.

Three members and alternates representing health professionals and three members and alternates representing patients' associations were appointed.

The successful candidates were appointed for a three-year-mandate starting 1 August 2023.

The Commission appointed the alternates after consultation with the European Parliament.

The deadline for submission of applications was 3 November 2022.

Civil Society representatives: Call for expressions of interest is open for the EMA Management Board

The Commission launched a selection procedure to appoint the Civil Society representatives in the Management Board of the European Medicines Agency (EMA).

Four members from Civil Society were appointed: two members representing patients' organisations, one member representing doctors' organisations and one member representing veterinarians' organisations.

The successful candidates were appointed for a three-year-mandate starting on 15 June 2022.

The Application Form and Declaration of Interests Form can be downloaded here:

The deadline for submission of applications expired on 5 November 2021.

Representatives of Patients' Associations and Clinicians: Call for expressions of interest is open for the EMA Committee for Advanced Therapies

The Commission launchieda selection procedure to appoint the Representatives of Patients' Associations and Clinicians in the Committee for Advanced Therapies of the European Medicines Agency.

The Commission appointed:

  • Two members and two alternates representing clinicians
  • Two members and two alternates representing patients' associations

The successful candidates were appointed for a three-year-mandate starting on 1 July 2022.

To download the Declaration of Interests Form please follow the link:

The deadline for submission of applications expired on 29 October 2021.

Civil Society representatives: Call for expressions of interest is open for the EMA Pharmacovigilance Risk Assessment Committee

The Commission launched a selection procedure to appoint the Civil Society representatives in the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency (EMA).

The Commission appointed:

  • One representative of patients' organisation and one alternate.
  • One representative of health professionals' organisation and one alternate.

The successful candidates were appointed for a three-year-mandate starting on 1 March 2022.

The Application Form and Declaration of Interests Form can be downloaded here:

The deadline for submission of applications expired on 18 October 2021.

Members representing patients' organisations: Call for expressions of interest for the EMA COMP Committee

The Commission launched a selection procedure to appoint the members representing patients' organisations to the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA).

Three members will be appointed.

The successful candidates will be appointed for a three-year-mandate starting on 1 July 2021.

The Application Form and Declaration of Interests Form can be downloaded here:

The deadline for submission of applications expired on 18 December 2020.

Additional information:

Independent Scientific experts: Call for expressions of interest for the EMA PRAC Committee

The Commission launched a selection procedure to appoint the Independent Scientific Experts to the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA)

Six Independent scientific experts will be appointed.

The successful candidates will be appointed for a three-year-mandate starting from 2 July 2021.

The Application Form and Declaration of Interests Form can be downloaded here:

The original deadline for submission of applications expired on 4 December 2020.

Additional information: